Palmitoyl acyltransferase Aph2 in cardiac function and the development of cardiomyopathy
Palmitoyl acyltransferase Aph2 in cardiac function and the development of cardiomyopathy
复制标题
棕榈酰酰基转移酶 Aph2 在心脏功能和心肌病发展中的作用
DOI:
10.1073/pnas.1518368112
复制
发表时间:
2015-12
影响因子:
11.1
通讯作者:
Li, Baojie
中科院分区:
文献类型:
--
作者:
Thibault, Helene;Scherrer-Crosbie, Marielle;Goff, Stephen P.;Li, Baojie
Significance The etiology of heart disorders remains poorly understood. In this paper, we show for the first time to our knowledge, that protein palmitoylation plays a critical role in heart structure and function. We demonstrate that Aph2 (Ablphilin 2) is a palmitoyl transferase and identify phospholamban, a cardiomyopathy disease gene, as a substrate. Some of the heart defects of an Aph2−/−mouse can be rescued by phospholamban ablation. In addition, the present study reveals critical roles for protein palmitoylation in embryonic/postnatal survival and eye development. Protein palmitoylation regulates many aspects of cell function and is carried out by acyl transferases that contain zf-DHHC motifs. The in vivo physiological function of protein palmitoylation is largely unknown. Here we generated mice deficient in the acyl transferase Aph2 (Ablphilin 2 or zf-DHHC16) and demonstrated an essential role for Aph2 in embryonic/postnatal survival, eye development, and heart development. Aph2−/− embryos and pups showed cardiomyopathy and cardiac defects including bradycardia. We identified phospholamban, a protein often associated with human cardiomyopathy, as an interacting partner and a substrate of Aph2. Aph2-mediated palmitoylation of phospholamban on cysteine 36 differentially alters its interaction with PKA and protein phosphatase 1 α, augmenting serine 16 phosphorylation, and regulates phospholamban pentamer formation. Aph2 deficiency results in phospholamban hypophosphorylation, a hyperinhibitory form. Ablation of phospholamban in Aph2−/− mice histologically and functionally alleviated the heart defects. These findings establish Aph2 as a critical in vivo regulator of cardiac function and reveal roles for protein palmitoylation in the development of other organs including eyes.
登录
查看更多内容
影响因子:
20.1
作者:
Zhang T;Guo T;Mishra S;Dalton ND;Kranias EG;Peterson KL;Bers DM;Brown JH
通讯作者:
Brown JH
影响因子:
4.5
作者:
Mill P;Lee AW;Fukata Y;Tsutsumi R;Fukata M;Keighren M;Porter RM;McKie L;Smyth I;Jackson IJ
通讯作者:
Jackson IJ
影响因子:
4
作者:
Linder, ME;Deschenes, RJ
通讯作者:
Deschenes, RJ
影响因子:
--
作者:
G. Chu;E. Kranias
通讯作者:
G. Chu;E. Kranias
DOI:
10.1172/jci16738
发表时间:
2003-03
期刊:
The Journal of clinical investigation
影响因子:
--
作者:
Qiujing Song;A. Schmidt;H. Hahn;Andrew N. Carr;Beate Frank;L. Pater;Michael J Gerst;Karen B. Young;B. Hoit;B. McConnell;K. Haghighi;C. Seidman;J. Seidman;G. Dorn;E. Kranias
通讯作者:
Qiujing Song;A. Schmidt;H. Hahn;Andrew N. Carr;Beate Frank;L. Pater;Michael J Gerst;Karen B. Young;B. Hoit;B. McConnell;K. Haghighi;C. Seidman;J. Seidman;G. Dorn;E. Kranias